Natera helps doctors give couples the best chance of having a healthy child, using the interlocking disciplines of medicine, genetics, statistics, and software engineering to enable highly reliable testing of multiple genes and chromosome copy number from a single cell.

Today, Natera’s technology is being offered through their partner IVF clinics for aneuploidy screening across all 24 chromosomes in time for Day 5 transfer. The company’s pre-implantation screening process was recently shown to be dramatically more effective than peer technologies in a study published in Human Reproduction.